Syntax Advisors, LLC Moderna, Inc. Transaction History
Syntax Advisors, LLC
- $57.7 Million
- Q3 2023
A detailed history of Syntax Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Syntax Advisors, LLC holds 2,155 shares of MRNA stock, worth $56,288. This represents 0.38% of its overall portfolio holdings.
Number of Shares
2,155
Previous 1,868
15.36%
Holding current value
$56,288
Previous $226,000
1.77%
% of portfolio
0.38%
Previous 0.35%
Shares
8 transactions
Others Institutions Holding MRNA
# of Institutions
854Shares Held
253MCall Options Held
23.9MPut Options Held
30.2M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.06 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$668 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$577 Million0.48% of portfolio
-
State Street Corp Boston, MA17.8MShares$464 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$232 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.2B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...